Reporting AF Recurrence After Catheter Ablation: The Burden Is on Us to Get it Right.

[1]  George A. Johnson,et al.  Recurrence of Atrial Fibrillation After Catheter Ablation or Antiarrhythmic Drug Therapy in the CABANA Trial. , 2020, Journal of the American College of Cardiology.

[2]  Hanyuan Shi,et al.  A RARE PRESENTATION OF CHAGASIC CARDIOMYOPATHY WITH STROKE , 2020 .

[3]  John Sapp,et al.  Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial. , 2019, Circulation.

[4]  Alexander Valys,et al.  Smartwatch Performance for the Detection and Quantification of Atrial Fibrillation. , 2019, Circulation. Arrhythmia and electrophysiology.

[5]  G. Hindricks,et al.  Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial , 2019, JAMA.

[6]  J. Healey,et al.  Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[7]  J. Steinberg,et al.  Thirty-Second Gold Standard Definition of Atrial Fibrillation and Its Relationship With Subsequent Arrhythmia Patterns: Analysis of a Large Prospective Device Database , 2018, Circulation. Arrhythmia and electrophysiology.

[8]  M. Chung,et al.  Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity A Scientific Statement From the American Heart Association , 2018, Circulation.

[9]  H. Sievers,et al.  Atrial Fibrillation Burden Estimates Derived from Intermittent Rhythm Monitoring are Unreliable Estimates of the True Atrial Fibrillation Burden , 2014, Pacing and clinical electrophysiology : PACE.

[10]  C. Morillo,et al.  Relationship of quality of life with procedural success of atrial fibrillation (AF) ablation and postablation AF burden: substudy of the STAR AF randomized trial. , 2013, The Canadian journal of cardiology.

[11]  J. Hartikainen,et al.  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. , 2012, The New England journal of medicine.

[12]  David Keane,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[13]  D. Lin,et al.  Efficacy and Risk of Atrial Fibrillation Ablation Before 45 Years of Age , 2010, Circulation. Arrhythmia and electrophysiology.

[14]  J. Ruskin,et al.  HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. , 2007, Heart rhythm.

[15]  Rahul Mehra,et al.  Comparison of continuous versus intermittent monitoring of atrial arrhythmias. , 2006, Heart rhythm.

[16]  F. Marchlinski,et al.  Time to recurrence of atrial fibrillation influences outcome following catheter ablation. , 2013, Heart rhythm.